• Home
  • About us
  • Log-In
  • Join Us
  • Sitemap
  • Recruit
실험정보 Q&A
자주묻는질문
클레임접수
클레임 진행조회
기기 A/S
실험기법
자료신청
논문자료
 제품안내  신경약학  신경약학 신제품

2008 신경약학 신제품

Cat. NO. Product Name & Pharmacological Action 업데이트
3308 Zileuton Dec 2008
Orally active 5-LOX inhibitor
3211 SB 525334 Dec 2008
Selective inhibitor of TGF-β type-I receptor (TGF-β RI, ALK-5)
3290 ZIP, Biotinylated Dec 2008
Biotinylated peptide for ZIP (Cat No. 2549)
3278 YM 511 Dec 2008
Potent aromatase (CYP19) inhibitor
2640 L-703,664 Dec 2008
Selective 5-HT1D receptor agonist
3101 XRP44X Dec 2008
Ras-Net pathway inhibitor
3052 RO-3 Dec 2008
Selective P2X2 and P2X2/3 antagonist
2188 Ro 0437626 Dec 2008
Selective P2X1 antagonist
2962 6'-GNTI Dec 2008
Selective κ/δ-opioid receptor heterodimer agonist
2787 BAPTA AM Dec 2008
Cell-permeable Ca2+ chelator
3140 PHA 767491 hydrochloride Dec 2008
Dual cdc7/cdk9 inhibitor. Also inhibits MK-2
3311 VU 0155041 sodium salt Dec 2008
Potent, positive allosteric mGlu4 agonist. Sodium salt of Cat. No. 3248
3117 Miglustat hydrochloride Dec 2008
Ceramide-specific glycosyltransferase inhibitor. Also inhibits α-glucosidase I and II
3117 Miglustat hydrochloride Dec 2008
Ceramide-specific glycosyltransferase inhibitor. Also inhibits α-glucosidase I and II
3248 VU 0155041 Dec 2008
Potent, positive allosteric mGlu4 agonist
3214 RETRA hydrochloride Nov 2008
Antitumour agent; suppresses mutant p53-bearing cancer cells
3241 Ko 143 Nov 2008
Potent and selective BCRP inhibitor
1271 RJR 2429 Nov 2008
Nicotinic receptor agonist
3148 Calcium chloride dihydrate Nov 2008
Commonly used laboratory reagent
3147 Potassium Chloride Nov 2008
Commonly used laboratory reagent
3178 Sodium hydroxide Nov 2008
Commonly used laboratory reagent
3146 Sodium Chloride Nov 2008
Commonly used laboratory reagent
3152 Sodium bicarbonate Nov 2008
Commonly used laboratory reagent
2907 SU 9516 Nov 2008
Potent cdk2 inhibitor
3279 UTPγS trisodium salt Nov 2008
Selective P2Y2/4 agonist
3023 CP 31398 Nov 2008
p53-stabilising agent
3179 Water, sterile filtered Nov 2008
Sterile water
3239 Finasteride Nov 2008
Type II 5α-reductase Inhibitor
3293 Finasteride Nov 2008
Type II 5α-reductase Inhibitor
3212 CP 376395 Nov 2008
Potent and selective CRF1 antagonist
1146 MDL 28170 Nov 2008
Potent, selective calpain and cathepsin B inhibitor
3292 Metyrapone Nov 2008
11-β hydroxylase inhibitor
3286 Milnacipran hydrochloride Nov 2008
5-HT and noradrenalin re-uptake inhibitor (SNRI)
3256 Metoprolol tartrate Nov 2008
Selective β1 antagonist. Also inhibits endothelin-1 production
3260 Epirubicin hydrochloride Nov 2008
Inhibits DNA synthesis and function. Inhibits DNA topoisomerase II.
3283 LY 487379 hydrochloride Nov 2008
Positive allosteric modulator selective for mGlu2
3202 Echistatin Nov 2008
αVβ3 and glycoprotein IIb/IIIa (αIibβ3) inhibitor
2412 BIBO 3304 Nov 2008
Highly selective NPY Y1 receptor antagonist
2911 Ro 04-6790 Nov 2008
Potent and selective 5-HT6 antagonist
2948 (R)-(+)-m-Nitrobiphenyline oxalate Nov 2008
Potent α2C agonist
3253 Triptolide Oct 2008
Inhibits TNF-α-induced NF-κB activation
3273 Isoflurane Oct 2008
Anaesthetic agent
3269 SD 208 Oct 2008
Potent ATP-competitive TGF-βRI inhibitor
3287 Prochlorperazine dimaleate Oct 2008
D2 receptor antagonist. Also 5-HT3 and nAChR antagonists
3288 Oxprenolol hydrochloride Oct 2008
Non-selective β antagonist
3277 Pentamidine isethionate Oct 2008
Antimicrobial that antagonises NMDA receptors
3247 Fentanyl citrate Oct 2008
Potent and selective μ agonist
2957 Org 27569 Oct 2008
Potent allosteric CB1 modulator
3271 Compound 401 Oct 2008
Selective DNA-PK and mTOR inhibitor
3267 Thiostrepton Oct 2008
Antibiotic, inhibits protein synthesis
3246 LY 354740 Oct 2008
Potent and highly selective group II mGlu agonist
3276 Mephenytoin Oct 2008
CYP2C19 substrate. Anticonvulsant
3238 TCS PrP Inhibitor 13 Oct 2008
Antiprion agent; potently inhibits PrP-res accumulation
3262 JNJ 1661010 Oct 2008
Selective, reversible FAAH inhibitor
3236 PACAP 6-38 Oct 2008
Potent PAC1 receptor antagonist
3129 BMS CCR22 22 Oct 2008
High affinity, potent CCR2 antagonist
3231 Ac9-25 Oct 2008
Annexin I N-terminal peptide. Acts as a FPR ligand
2220 FURA-2AM Oct 2008
Fluorescent Ca2+ indicator
3237 BIM 23042 Oct 2008
Selective neuromedin B receptor antagonist (NMB-R, BB1)
3089 CJ 033466 Oct 2008
Selective 5-HT4 partial agonist
3281 Canrenone Oct 2008
Mineralocorticoid receptor antagonist
3258 Mitomycin C Oct 2008
DNA cross-linking antitumour agent
3123 α-Conotoxin PnIA Oct 2008
Selective α3β2 nAChR antagonist
3193 Camostat mesylate Oct 2008
Orally active protease inhibitor
2969 SR 12813 Oct 2008
Pregnane X receptor (PXR) agonist
3099 GYKI 47261 dihydrochloride Oct 2008
Non-competitive AMPA antagonist
3259 Gemcitabine hydrochloride Oct 2008
DNA synthesis inhibitor
2732 BAY-u 3405 Oct 2008
Dual TP/DP2 (CRTH2) receptor antagonist
2928 CB 13 Oct 2008
Potent dual CB1/CB2 agonist
3190 Mirin Oct 2008
MRN-ATM pathway inhibitor
3257 5-Fluorouracil Oct 2008
Inhibits RNA and DNA synthesis
3032 THIQ Oct 2008
Potent and selective MC4R agonist
3215 ZIP (Scrambled) Oct 2008
Control peptide for ZIP (Cat. No. 2549)
3209 α,β-Methyleneadenosine 5'-triphosphate trisodium Sep 2008
Purinergic receptor agonist
3079 LY 334370 hydrochloride Sep 2008
Selective 5-HT1F agonist
3228 [Lys5,MeLeu9,Nle10 Sep 2008
Selective NK2 agonist
3120 a-Conotoxin AuIB Sep 2008
Selective a3b4 nAChR antagonist
3162 [Orn5]-URP Sep 2008
Urotensin II (UT) receptor antagonist
3189 SB 399885 hydrochloride Sep 2008
Potent and selective 5-HT6 antagonist
3154 DL-Dithiothreitol Sep 2008
Maintains SH groups in the reduced state
3245 ATP disodium salt Sep 2008
P2 purinergic agonist
3176 DMSO, sterile filtered Sep 2008
Solvent
3172 CHAPS Sep 2008
Zwitterionic detergent
3188 SB 699551 Sep 2008
Selective 5-ht5A antagonist
3093 Dorsomorphin dihydrochloride Sep 2008
Potent and selective AMPK inhibitor
3174 HEPES Sodium salt Sep 2008
Multipurpose buffer
3173 HEPES Sep 2008
Multipurpose buffer
3037 SU 5416 Sep 2008
VEGFR inhibitor. Also inhibits c-kit, Ret, c-Met and Flt-3
3107 SC 57461A Sep 2008
Selective inhibitor of LTA4 hydrolase
3203 Celastrol Sep 2008
Antioxidant and anti-inflammatory
3198 PSB 603 Sep 2008
Highly selective A2B antagonist
2855 B2 Sep 2008
Promotes inclusion formation in Huntingdon's and Parkinson's diseases
3205 ACV 1 Sep 2008
α9α10-selective antagonist
3207 Kifunensine Sep 2008
Inhibitor of class I α-mannosidases
3208 Swainsonine Sep 2008
Inhibitor of a-mannosidase II
2518 TC 1698 dihydrochloride Sep 2008
α7-selective agonist
2981 BIBR 1532 Sep 2008
Selective telomerase inhibitor
2953 CyPPA Sep 2008
Activator of SK2 and SK3 channels
3131 Ketamine hydrochloride Sep 2008
Non-competitive NMDA receptor antagonist
3134 PHA 568487 Sep 2008
α7-selective agonist
3114 Troglitazone Sep 2008
Selective PPARg agonist; antidiabetic agent
3078 LY 310762 Aug 2008
5-HT1D preferring antagonist
3143 KM 11060 Aug 2008
Corrects F508del-CFTR trafficking
3137 Neuropeptide FF Aug 2008
Endogenous anti-opioid
2993 RS 127445 hydrochloride Aug 2008
Selective, high affinity 5-HT2B antagonist
2604 Milameline hydrochloride Aug 2008
Muscarinic receptor agonist
3206 Doxercalciferol Aug 2008
Vitamin D 2 analogue, VDR agonist
3213 Methylene Blue Aug 2008
Biological stain
3195 Dynorphin A Aug 2008
Endogenous κ agonist
3196 Dynorphin B Aug 2008
Endogenous κ agonist
2728 ACET Aug 2008
Potent antagonist of GluR5-containing kainate receptors
3110 (-)-Cotinine Aug 2008
Major metabolite of nicotine
3141 VU 10010 Aug 2008
Selective allosteric potentiator of M4 receptors
3127 d[Leu4,Lys8]-VP Aug 2008
Selective V1b agonist
3126 d[Cha4]-AVP Aug 2008
Potent and selective human V1b agonist
3000 Iressa Aug 2008
Orally active, selective EGFR inhibitor
2995 NS 1738 Aug 2008
Positive allosteric modulator of a7 nAChR; active in vivo
3138 BAY-u 9773 Aug 2008
Dual CysLT1 and CysLT2 antagonist
2974 CCG 2046 Jul 2008
Inhibitor of regulator of G-protein signalling 4 (RGS4)
2776 FK 3311 Jul 2008
Cyclooxygenase-2 (COX-2) inhibitor
3124 α-Conotoxin EI Jul 2008
α1β1δγ selective nAChR antagonist
2799 Agatoxin IVA, Omega Jul 2008
Ca2+ channel blocker (P-type)
2802 Agatoxin TK, omega Jul 2008
Ca2+ channel blocker (P/Q-type)
2866 BYK 191023 dihydrochloride Jul 2008
Potent and selective inhibitor of iNOS
3121 α-Conotoxin PIA Jul 2008
Selective antagonist of a6-containing nicotinic receptors
3199 PSB 0788 Jul 2008
Selective A2B antagonist
3077 LY 272015 hydrochloride Jul 2008
High affinity 5-HT2B antagonist, orally active
3097 Pertussis Toxin Jul 2008
Catalyses ADP-ribosylation of Gi, Go and Gt
3048 Valerenic acid Jul 2008
Positive allosteric modulator of GABAA receptors
2908 EO 1428 Jul 2008
Selective inhibitor of p38a and p38b2
2741 Δ9-Tetrahydrocannabinol Jul 2008
Cannabinoid receptor agonist; psychoactive
3139 RC 160 Jul 2008
Somatostatin analogue
3095 [Ala2,8,9,11,19,22,24,25,27,28]-VIP Jul 2008
Highly selective VPAC1 agonist
3111 UDP disodium salt Jul 2008
Endogenous P2Y receptor agonist; selective for P2Y6
2854 Tandospirone hydrochloride Jul 2008
Selective 5-HT1A partial agonist
3136 2-Chloroadenosine Jul 2008
Adenosine receptor agonist
3109 Furosemide Jul 2008
Na+/2Cl-/K+ (NKCC) cotransporter blocker. Also antagonises GABA
3108 Bumetanide Jul 2008
Na+/2Cl-/K+ (NKCC) cotransporter blocker
3026 ONO 1078 Jul 2008
Selective CysLT1 antagonist
3119 α-Conotoxin ImI Jul 2008
α7 and α9 selective nAChR antagonist
1796 5-Oxo-ETE Jul 2008
Oxoeicosanoid receptor agonist
2896 HC 030031 Jun 2008
Selective TRPA1 blocker
3040 WS 12 Jun 2008
TRPM8 agonist; cooling agent
2729 CP 80633 Jun 2008
Selective PDE4 inhibitor
3118 Ranolazine dihydrochloride JUN 2008
Anti-anginal, activates pyruvate dehydrogenase
3103 Fumonisin B1 Jun 2008
Inhibitor of sphingosine N-acyltransferase
2789 NFPS Jun 2008
Selective non-transportable GlyT1 inhibitor
2950 Acetyl-Calpastatin (184-210) (human) Jun 2008
Selective calpain inhibitor
3061 Macbecin I Jun 2008
Hsp90 inhibitor
2557 Phencyclidine hydrochloride Jun 2008
Non-competitive NMDA receptor antagonist
3017 1-Methylpsilocin Jun 2008
Potent and selective 5-HT2C agonist
3087 Lorazepam Jun 2008
Acts at the benzodiazepine modulatory site
2733 U 90042 Jun 2008
GABAA receptor ligand
2814 PI 828 Jun 2008
PI 3-kinase inhibitor, more potent than LY 294002 (Cat.No. 1130)
3054 VIP, [D-p-Cl-Phe6,Leu17]- Jun 2008
Selective VIP receptor antagonist
1340 α-Conotoxin MII Jun 2008
Potent α3β2 and β3 subunit selective nicotinic antagonist
2945 SNX 482 Jun 2008
Potent and selective CaV2.3 blocker (R-type)
3081 Nafamostat mesylate Jun 2008
Serine protease inhibitor, inhibits tryptase
3069 Acephate Jun 2008
Anticholinesterase insecticide
3096 Carbenoxolone disodium May 2008
Gap junction blocker. Also inhibitor of 11 β-hydroxysteroid dehydrogenase
3075 GSK 4716 May 2008
Selective ERRγ and ERRβ agonist
2939 A 83-01 May 2008
Selective inhibitor of ALK5, ALK4 and ALK7
2760 L-748,337 May 2008
Selective β3 antagonist
2840 AICAR May 2008
AMPK activator
3090 Gallein May 2008
Inhibitor of βγ signalling
3082 Tempol May 2008
Superoxide scavenger; antioxidant
3067 Desipramine hydrochloride May 2008
Selective inhibitor of noradrenalin transporters
2833 Cocaine hydrochloride May 2008
Inhibitor of monoamine transporters
3046 Alphaxalone May 2008
Direct activator and potentiator of GABAA
2970 RU 26752 May 2008
Mineralocorticoid receptor antagonist
2749 Dexmedetomidine hydrochloride May 2008
Active isomer of Cat. No. 2023
3070 Thioridazine hydrochloride May 2008
Dopamine receptor antagonist; antipsychotic
3050 Tamsulosin hydrochloride May 2008
Selective α1A antagonist
2808 Buprenorphine hydrochloride May 2008
Opioid receptor ligand
2988 VULM 1457 May 2008
Acyl-CoA: cholesterol acyltransferase (ACAT) inhibitor
2980 CX 546 May 2008
AMPA receptor potentiator
3051 TLQP 21 May 2008
VGF-derived peptide
2341 A 80426 mesylate May 2008
High affinity α2 antagonist and 5-HT uptake inhibitor
2914 Batrachotoxin May 2008
Voltage-gated Na+ channel activator
2556 PNU 109291 May 2008
Potent and selective 5-HT1D agonist
2837 BDNF (human) Apr 2008
Activates TrkB and p75 receptors
3041 CP 809101 hydrochloride Apr 2008
Potent and selective 5-HT2C agonist
3085 Ziprasidone hydrochloride Apr 2008
5-HT2A/D2 antagonist; atypical antipsychotic
2606 PD 144418 oxalate Apr 2008
High affinity, selective σ1 ligand
3063 1-Naphthyl PP1 Apr 2008
Src family Kinase inhibitor; also inhibits c-Abl
2902 D 4476 Apr 2008
Selective CK1 inhibitor. Also inhibits TGF-β RI
3072 Diphenhydramine hydrochloride Apr 2008
H1 receptor antagonist
3071 Dextromethorphan hydrobromide Apr 2008
NMDA receptor antagonist
3033 Cortistatin-8 Apr 2008
Ghrelin receptor antagonist
3068 Tetraethylammonium chloride Apr 2008
Non-selective K+ channel blocker
2919 NPE-caged-HPTS Apr 2008
Caged fluorescent pH indicator
3083 DMCM hydrochloride Apr 2008
Benzodiazepine inverse agonist
2976 A 803467 Apr 2008
Selective NaV1.8 blocker
3045 Pemoline Apr 2008
CNS stimulant, indirect monoamine agonist
2947 Methimepip dihydrobromide Apr 2008
Extremely selective H3 agonist
2994 Signal Enhancer Hikari Apr 2008
Antibody-antigen signal enhancer
3025 AA 2414 Apr 2008
Thromboxane A2 (TP) receptor antagonist
1985 PNU 142633 Apr 2008
Highly selective 5-HT1D agonist
2926 FPA 124 Apr 2008
PKB/Akt inhibitor
2967 Phenserine Apr 2008
Cholinesterase inhibitor
3058 Ellagic acid Apr 2008
Selective inhibitor of CK2. Also inhibits glutathione S-transferase
2813 D-Amphetamine sulfate Apr 2008
Induces dopamine, 5-HT and noradrenalin release
3022 Edelfosine Apr 2008
Selective PI-PLC inhibitor, also PAF receptor agonist
2250 SL 0101-1 Apr 2008
Selective p90 ribosomal S6 kinase (RSK) inhibitor
2989 Epoprostenol Apr 2008
Endogenous IP receptor agonist
2790 K 579 Apr 2008
Dipeptidyl peptidase IV (DPP-IV) inhibitor
3055 BCECF-AM Apr 2008
pH indicator
2905 TB 21007 Apr 2008
α5-selective GABAA inverse agonist
3015 2-Furoyl-LIGRLO-amide Apr 2008
Potent and selective PAR2 agonist
3043 AC 45594 Mar 2008
SF-1 inverse agonist
3056 Pentoxifylline Mar 2008
PDE inhibitor
2942 CI 1020 Mar 2008
Highly selective, orally active ETA antagonist
3057 Lidocaine Mar 2008
Na+ channel blocker
2963 MMPIP hydrochloride Mar 2008
Potent, allosteric mGlu7-selective antagonist
3003 Coenzyme Q10 Mar 2008
Antioxidant
2930 PI 103 hydrochloride Mar 2008
Inhibitor of PI 3-kinase, mTOR and DNA-PK
3007 Apelin-17 (human, bovine) Mar 2008
Endogenous APJ receptor agonist
3012 α-CGRP (human) Mar 2008
CGRP receptor agonist
3016 Miconazole nitrate Mar 2008
Antifungal agent
2738 Org 20599 Mar 2008
Positive allosteric modulator and direct agonist of GABAA receptors
2805 Diazepam Mar 2008
Benzodiazepine agonist
2643 DOI hydrochloride Mar 2008
Mixed 5-HT2A/2C agonist
3008 Galanin (porcine) Mar 2008
Galanin receptor agonist
3005 [Des-Arg9]-Bradykinin Mar 2008
Bradykinin receptor agonist (B1 > B2)
3013 [Nle4,D-Phe7]-α-MSH Mar 2008
Melanocortin receptor agonist
3010 SLIGKV-NH2 Mar 2008
PAR2 receptor agonist
3004 Bradykinin Mar 2008
Endogenous agonist at bradykinin receptors (B2 > B1)
3009 Neuropeptide W-23 (human) Mar 2008
Endogenous NPBW1 and NPBW2 receptor agonist
2951 [Des-octanoyl]-Ghrelin (rat) Mar 2008
Major circulating form of ghrelin; devoid of activity at GHS receptor
3011 Parathyroid hormone (1-34) (human) Mar 2008
Parathyroid hormone (PTH) receptor agonist
3006 Gastrin I (human) Mar 2008
Selective CCK2 agonist
2832 Midazolam hydrochloride Mar 2008
Benzodiazepine agonist
2849 SecinH3 Mar 2008
Sec7-specific GEF inhibitor (cytohesins)
2965 Diprenorphine Mar 2008
Non-selective opioid antagonist
3014 HOE 140 Mar 2008
Potent and selective B2 antagonist
3028 Rp-8-Br-PET-cGMPS Mar 2008
Protein kinase G inhibitor
2985 LEP (116-130) (mouse) Mar 2008
Synthetic leptin peptide fragment
2822 Testosterone Mar 2008
Endogenous androgen receptor agonist
2992 PKC 412 Feb 2008
Protein kinase C inhibitor
2660 L-364,373 Feb 2008
KCNQ1 (KVLQT1) channel activator, activates IKs
3002 Idebenone Feb 2008
Antioxidant and neuroprotective agent
2391 Astressin 2B Feb 2008
Selective CRF2 antagonist
2778 Antalarmin hydrochloride Feb 2008
CRF1 antagonist
2897 Dynasore Feb 2008
Non-competitive dynamin inhibitor
2901 SB 242084 Feb 2008
Selective 5-HT2C antagonist; brain penetrant
2972 A 438079 hydrochloride Feb 2008
Competitve P2X7 antagonist
2925 LP 12 hydrochloride Feb 2008
5-HT7 agonist
2964 Doxazosin mesylate Feb 2008
α1-adrenoceptor antagonist
1051 Zinterol hydrochloride Feb 2008
Selective β2 agonist
2736 Sazetidine A dihydrochloride Feb 2008
Subtype-selective α4β2 receptor desensitiser
2033 Pentostatin Feb 2008
Adenosine deaminase inhibitor
2946 TRAM 34 Feb 2008
Highly selective IKCa1 channel inhibitor
2968 Spironolactone Feb 2008
Mineralocorticoid receptor antagonist
2707 BIBP 3226 trifluoroacetate Feb 2008
Mixed NPY Y1 and NPFF receptor antagonist
2532 TFB-TBOA Feb 2008
High affinity EAAT1 and EAAT2 blocker
2797 O-1602 Feb 2008
Potent GPR55 receptor agonist
2929 PEPA Feb 2008
Allosteric potentiator of AMPA receptor desensitisation
1495 Combretastatin A4 Feb 2008
Inhibits tubulin polymerisation. Antitumour, antiangiogenic and antimetastatic
2975 Sarcosine Feb 2008
GlyT1 inhibitor
2973 Piracetam Feb 2008
Nootropic; modulates Na+-flux at AMPA receptors
2959 Lercanidipine hydrochloride Feb 2008
L-type Ca2+ channel blocker
2960 Felodipine Feb 2008
L-type Ca2+ channel blocker
0721 Aminopotentidine Feb 2008
H2 antagonist
2977 GW 843682X Feb 2008
Selective inhibitor of PLK1 and PLK3
2603 PD 168368 Feb 2008
Selective neuromedin B receptor antagonist (NMB-R, BB1)
2828 NU 7026 Feb 2008
Selective DNA-dependent protein kinase inhibitor
2958 DSP-4 Jan 2008
Adrenergic neurotoxin
2906 TRO 19622 Jan 2008
Binds voltage-dependent anion channel (VDAC)
2613 NSC 87877 Jan 2008
Potent inhibitor of shp2 and shp1 PTP
2924 NBMPR Jan 2008
Equilibrative nucleoside transporter 1 (ENT1) inhibitor
2680 O-2545 hydrochloride Jan 2008
High affinity, water-soluble CB1/CB2 agonist
2915 MRS 2690 Jan 2008
Potent P2Y14 agonist
2938 SD 169 Jan 2008
Selective, orally active p38α inhibitor
2831 Bupropion hydrochloride Jan 2008
Non-selective inhibitor of dopamine and noradrenalin transporters
2672 Taltirelin Jan 2008
Synthetic thyrotropin-releasing hormone (TRH) analogue
2734 U 89843A Jan 2008
Positive allosteric modulator of GABAA
2038 Iloprost Jan 2008
Prostacyclin (PGI2) analogue
2903 Granisetron hydrochloride Dec 2007
5-HT3 antagonist
2867 Flupirtine maleate Dec 2007
K+ channel activator
2726 SB 258719 hydrochloride Dec 2007
Selective 5-HT7 antagonist
2940 PAF (C16) Dec 2007
Endogenous platelet-activating factor (PAF)
2739 U 92016A Dec 2007
Selective 5-HT1A agonist
2782 TCS 46b Dec 2007
Orally active, subtype-selective NR1A/NR2B antagonist
2607 CI 988 Dec 2007
Potent and selective CCK2 antagonist
2608 PD 135158 Dec 2007
Potent and selective CCK2 antagonist
2927 WS 3 Nov 2007
TRPM8 agonist; cooling agent
2779 CP 154526 Nov 2007
Selective, non-peptide CRF1 antagonist
2836 Arachidonyl serotonin Nov 2007
Dual FAAH/TRPV1 blocker
2520 PD 166793 Nov 2007
Broad spectrum matrix metalloproteinase (MMP) inhibitor
2921 MTEP Nov 2007
Potent, selective mGlu5 antagonist
2816 Withaferin A Nov 2007
Inhibits NF-κB activation
2628 ONO 4817 Nov 2007
Broad spectrum MMP inhibitor
2602 PD 176252 Nov 2007
GRP (BB2) and NMB (BB1) receptor antagonist
2934 Vasopressin, [Lys8]- Nov 2007
Antidiuretic hormone
2935 Vasopresssin, [Arg8]- Nov 2007
Antidiuretic hormone
2768 PQ 401 Nov 2007
IGF-IR inhibitor
2931 Spinorphin Nov 2007
Potent P2X3 antagonist
2783 DPPI 1c hydrochloride Nov 2007
Dipeptidyl peptidase IV (DPP-IV) inhibitor
2769 BX 513 hydrochloride Nov 2007
Selective CCR1 antagonist
2727 Zoniporide dihydrochloride Nov 2007
Selective NHE-1 inhibitor
2683 PSB 603 Nov 2007
Extremely selective A2B antagonist
2753 A 350619 hydrochloride Nov 2007
Soluble guanylyl cyclase (sGC) activator
2842 BIM 23052 Nov 2007
sst5 agonist
2852 Adapalene Nov 2007
RARβ and RARγ agonist
2874 Luteolin Nov 2007
Anti-inflammatory, antioxidant and free radical scavenger
2444 (1R,1'S,3'R/1R,1'R,3'S)-L-054,264 Nov 2007
Potent and selective sst2 agonist
2917 Venlafaxine hydrochloride Nov 2007
Dual serotonin/noradrenaline reuptake inhibitor
2851 Nefiracetam Nov 2007
Cognitive enhancer
2770 Philanthotoxin 74 Nov 2007
GluR1/2 selective AMPA antagonist
2338 MK 571 Nov 2007
Potent CysLT1 (LTD4) inverse agonist. Also MRP inhibitor
2910 H 89 dihydrochloride Nov 2007
Protein kinase A inhibitor
2891 Ondansetron hydrochloride Nov 2007
Selective 5-HT3 antagonist
2820 (+)-Tubocurarine chloride Nov 2007
Nicotinic receptor antagonist
2864 Metformin hydrochloride Nov 2007
Activator of LKB1/AMPK; antidiabetic agent
2890 Tocriscreen™ Mini Oct 2007
1120 biologically active compounds pre-dissolved in DMSO (50μl 10mM solutions)
2884 Tocriscreen™ Total Oct 2007
1120 biologically active compounds pre-dissolved in DMSO (250μl 10mM solutions)
2786 BAPTA Oct 2007
Selective calcium chelator
2724 SB 265610 Oct 2007
Potent CXCR2 antagonist
2598 (±)-J 113397 Oct 2007
Potent and selective NOP antagonist
2873 Leuprolide Oct 2007
GnRH (LHRH) receptor agonist
2843 Mecamylamine hydrochloride Oct 2007
Noncompetitive nicotinic receptor antagonist
2810 Carbamoylcholine chloride Oct 2007
Cholinergic receptor agonist
2754 TCS 401 Oct 2007
Selective inhibitor of PTP1B
2823 α-Estradiol Oct 2007
Endogenous estrogen receptor ligand
1521 LY 233053 Oct 2007
Competitive NMDA receptor antagonist
2877 MNS Oct 2007
Selective inhibitor of Src and Syk
2761 DFMO Oct 2007
Ornithine decarboxylase inhibitor
2812 Heparin sodium salt Oct 2007
Anticoagulant
2745 U 93631 Oct 2007
GABAA receptor antagonist
2757 UCB 35625 Oct 2007
Potent CCR1 and CCR3 antagonist
2595 J 113863 Oct 2007
Potent CCR1 chemokine receptor antagonist
2780 EX 527 Oct 2007
Selective SIRT1 inhibitor
2865 Risperidone Oct 2007
Mixed 5-HT2A/D2 antagonist
2771 M 344 Oct 2007
Histone deacetylase inhibitor
2730 AG 045572 Oct 2007
Selective GnRH receptor antagonist
2845 IBMX Oct 2007
PDE inhibitor (non-selective)
2838 (R)-(-)-Phenylephrine hydrochloride Oct 2007
α1-adrenoceptor agonist
2875 Homovanillic acid Oct 2007
Fluorimetric reagent
2735 PNU 96415E Oct 2007
D4 and 5-HT2A antagonist; antipsychotic
2705 Liarozole hydrochloride Oct 2007
Cytochrome P450 inhibitor; blocks retinoic acid metabolism
2746 Amperozide hydrochloride Oct 2007
Atypical antipsychotic; high affinity 5-HT2 ligand
2844 Mosapride citrate Oct 2007
5-HT4 agonist and 5-HT3 antagonist
2784 Acipimox Oct 2007
Antilipolytic agent
2807 EGTA Sep 2007
Calcium chelating agent
2815 Valproic acid, sodium salt Sep 2007
Histone deacetylase inhibitor
2839 Levetiracetam Sep 2007
Anti-epileptic; binds SV2A
2806 Alprenolol hydrochloride Sep 2007
β antagonist
2821 Sodium Orthovanadate Sep 2007
Protein tyrosine phosphatase inhibitor
2796 (S)-(+)-Ibuprofen Sep 2007
Cyclooxygenase inhibitor (COX-1 > COX-2)
2798 Stattic Sep 2007
Selective STAT3 inhibitor
2794 PP 3 Sep 2007
Negative control for PP 2 (Cat. No. 1407)
2785 Strychnine hydrochloride Sep 2007
Competitive glycine receptor antagonist
2841 Curcumin Sep 2007
Antitumour, anti-inflammatory and antioxidant
1932 U 46619 Sep 2007
Potent, stable thromboxane A2 (TP) receptor agonist
2811 EDTA Sep 2007
Chelating agent
2737 TC 2559 difumarate Sep 2007
Selective partial agonist at a4b2 receptors
2809 Acetylcholine chloride Sep 2007
Endogenous neurotransmitter
2719 RWJ 21757 Sep 2007
Toll-like receptor 7 (TLR7) agonist
2681 17-PA Sep 2007
Antagonist of neurosteroid potentiation and direct gating of GABAA
2752 MRS 1754 Sep 2007
Selective A2B antagonist
2747 NNC 05-2090 hydrochloride Sep 2007
GABA uptake inhibitor; moderately BGT-1 selective
1519 Quinelorane hydrochloride Sep 2007
D2 and D3 agonist
2398 SNAP 5089 Sep 2007
Subtype selective α1A-adrenoceptor antagonist
2795 Theophylline Sep 2007
Bronchodilator, anti-inflammatory and immunomodulator
2824 β-Estradiol Sep 2007
Endogenous ER ligand
2835 Progesterone Sep 2007
Endogenous progesterone receptor agonist
2793 Caffeine Aug 2007
CNS stimulant
2777 Nefazodone hydrochloride Aug 2007
5-HT2A antagonist and 5-HT uptake inhibitor. Antidepressant
2034 ROS 234 dioxalate Aug 2007
Potent H3 antagonist
2775 Probucol Aug 2007
Antioxidant, anti-inflammatory and hypocholesterolaemic agent
1435 SQ 22536 Aug 2007
Adenylyl cyclase inhibitor
1980 L-817,818 Aug 2007
Potent and selective sst5 agonist
2764 GP 1a Aug 2007
Highly selective CB2 agonist
2601 Cyprodime hydrochloride Aug 2007
Selective μ antagonist
2624 Decitabine Aug 2007
DNA methyltransferase inhibitor
2759 B-HT 920 Aug 2007
D2 receptor agonist. Also α2 agonist and 5-HT3 antagonist
2725 SB 225002 Jul 2007
Potent and selective CXCR2 antagonist
2669 TC 1 Jul 2007
High affinity δ1 ligand
2646 HDS 029 Jul 2007
Potent inhibitor of the erbB receptor family
2743 Caffeic acid phenethyl ester Jul 2007
Specific inhibitor of NF-kB activation
2748 KF 38789 Jul 2007
Selective inhibitor of P-selectin-mediated cell adhesion
2519 T 98475 Jul 2007
Gonadotropin-releasing hormone (GnRH, LHRH) receptor antagonist
2402 MRS 2211 Jul 2007
Competitive P2Y13 antagonist
2718 LY 364947 Jul 2007
Selective inhibitor of TGF-β type-I receptor (TGF-β RI, ALK-5)
2636 Ivachtin Jul 2007
Potent caspase-3 inhibitor
2755 DCA Jul 2007
Mitochondrial pyruvate dehydrogenase kinase (PDK) inhibitor
2715 3-Phenacyl UDP disodium salt Jul 2007
Potent and selective P2Y6 agonist
2750 U 83836E Jul 2007
Antioxidant; inhibits lipid peroxidation
1571 Cucurbitacin I Jul 2007
Selective inhibitor of STAT3/JAK2 signalling
2665 BMS 191011 Jul 2007
Potent Maxi-K channel opener (BKCa, KCa1.1)
2731 CGP 57380 Jul 2007
Selective inhibitor of Mnk1
2722 Catestatin Jul 2007
Inhibitor of nicotinic cholinergic-stimulated catecholamine secretion
1626 Calphostin C Jul 2007
Potent, selective and photo-dependent PKC inhibitor
2756 Arachidonic acid (in Tocrisolve™ 100) Jul 2007
Endogenous free fatty acid (in water-soluble emulsion)
2701 YM 90K hydrochloride Jul 2007
Selective AMPA antagonist
2742 Reserpine Jul 2007
Inhibitor of vesicular monoamine transport
2508 Trap 101 Jul 2007
Potent and selective NOP antagonist
2717 BIM 189 Jul 2007
Bombesin antagonist
2716 BIM 187 Jul 2007
Bombesin/GRP receptor agonist
2711 Bay 55-9837 Jul 2007
Potent and selective VPAC2 agonist
2693 PHA 665752 Jul 2007
Potent and selective cMET inhibitor
2631 Marimastat Jun 2007
Broad spectrum MMP inhibitor
1567 Thiolutin Jun 2007
Antibiotic. Inhibits vitronectin cell adhesion
2599 OSU 6162 hydrochloride Jun 2007
Dopamine stabiliser
2635 NGB 2904 Jun 2007
Potent and selective D3 antagonist
2638 ST 91 Jun 2007
α2 agonist, putative α2C agonist
2253 Go 6976 Jun 2007
Potent protein kinase C inhibitor; selective for α and β isozymes
2700 Calcipotriol Jun 2007
Vitamin D3 analogue
2633 WAY 170523 Jun 2007
Potent and selective inhibitor of MMP-13
2676 Y 134 Jun 2007
Selective estrogen receptor modulator (SERM), selective for ERα
2678 GP 2a Jun 2007
Selective CB2 agonist
2560 SB 218078 Jun 2007
Inhibitor of checkpoint kinase 1 (Chk1)
2709 Cilastatin sodium Jun 2007
Dipeptidase inhibitor
2699 AR-M 1896 Jun 2007
Selective GalR2 agonist
1524 LY 288513 Jun 2007
Selective CCK2 antagonist
2684 SN 38 Jun 2007
DNA topoisomerase I inhibitor; antitumour
2539 IKK 16 Jun 2007
Selective inhibitor of IKK
2605 PD 198306 Jun 2007
Selective inhibitor of MEK1/2
2662 PHTPP May 2007
Selective ERb antagonist
2723 Anti-NR1 May 2007
Antibody recognising rat NR1 subunits
2651 AEG 3482 May 2007
Inhibitor of JNK signalling
2698 M871 May 2007
Selective GalR2 agonist
2651 AEG 3482 May 2007
Inhibitor of JNK signalling
2632 CL 82198 hydrochloride May 2007
Selective inhibitor of MMP-13
1384 McN-A 343 May 2007
Selective M1 muscarinic agonist
2706 Temozolomide May 2007
DNA-methylating antitumour agent
2691 Moexipril hydrochloride May 2007
Angiotensin-converting enzyme (ACE) inhibitor
2677 JLK 6 May 2007
Inhibitor of g-secretase-mediated bAPP processing
2639 CGK 733 May 2007
Selective inhibitor of ATR and ATM kinases
2675 ZJ 43 May 2007
Glutamate carboxypeptidase II and III (NAALADase, NAAG peptidase) inhibitor
2720 Anti-NR2A May 2007
Antibody recognising mouse NR2A subunits
2697 M617 May 2007
Selective GalR1 agonist
2696 Galanin (1-29) (rat, mouse) May 2007
Non-selective galanin receptor agonist
2664 Cabergoline May 2007
Selective D2-like agonist
2652 WAY 213613 May 2007
Potent, nonsubstrate EAAT2 inhibitor
2609 Ryuvidine May 2007
Cyclin-dependent kinase 4 (cdk4) inhibitor
2507 J 104129 fumarate May 2007
Potent, selective M3 antagonist
2673 Acarbose May 2007
Glucosidase a inhibitor (intestinal)
2663 CB 65 May 2007
High affinity, selective CB2 agonist
2405 p-DITC-APEC May 2007
Irreversible A2A agonist
1972 Tianeptine sodium salt May 2007
Selective facilitator of 5-HT uptake; antidepressant
2649 GW 9508 Apr 2007
Potent and selective GPR40 agonist
2694 PD 407824 Apr 2007
Selective inhibitor of Chk1 and Wee1
1587 Ro 32-0432 hydrochloride Apr 2007
Potent, orally active PKC inhibitor
2695 Dexfenfluramine hydrochloride Apr 2007
5-HT re-uptake inhibitor. Also stimulates 5-HT release
2689 POM 1 Apr 2007
Inhibitor of E-NTPDases
2641 L-368,899 hydrochloride Apr 2007
Potent, non-peptide oxytocin receptor antagonist
2661 UCL 2077 Apr 2007
Slow afterhyperpolarisation (sAHP) channel blocker
2690 Locustatachykinin I Apr 2007
Insect tachykinin-related peptide (TRP)
2647 NSC 632839 hydrochloride Apr 2007
Inhibitor of ubiquitin isopeptidase activity
2653 Pifithrin-μ Apr 2007
Inhibitor of p53-mitochondrial binding
2688 CPT 11 Apr 2007
DNA topoisomerase I inhibitor; antitumour
2615 PD 158780 Apr 2007
Potent erbB receptor family inhibitor
2685 Carvedilol Apr 2007
β-adrenoceptor and α1-adrenoceptor antagonist
2687 Pentylenetetrazole Apr 2007
CNS stimulant
2285 Go 6983 Apr 2007
Broad spectrum PKC inhibitor
2658 Bucindolol Apr 2007
β1- and β2-adrenoceptor antagonist
2671 Budesonide Apr 2007
Synthetic glucocorticoid; anti-inflammatory and chemopreventive
2622 ARP 101 Apr 2007
Inhibitor of MMP-2
2591 TCS 359 Apr 2007
Potent FLT3 inhibitor
2666 JP 1302 dihydrochloride Mar 2007
Potent and selective α2C antagonist
2551 Calcitriol Mar 2007
Vitamin D receptor (VDR) agonist
2682 4-Phenylbutyrate, sodium Mar 2007
Histone deacetylase inhibitor
2190 SR 27897 Mar 2007
Potent and selective CCK1 antagonist
2645 Fananserin Mar 2007
5-HT2A antagonist. Also D4 antagonist
2634 DAPT Mar 2007
γ-secretase inhibitor
2656 Concanamycin A Mar 2007
H + -ATPase (vacuolar) inhibitor
2668 Artemisinin Mar 2007
AntimalVerdana agent
1811 Modafinil Mar 2007
Psychostimulant
2592 TCB-2 Mar 2007
Potent, high affinity 5-HT2A agonist
2485 Glycyl-H 1152 dihydrochloride Mar 2007
More selective analogue of Cat. No. 2414
2514 L-161,982 Mar 2007
Selective EP4 receptor antagonist
2542 Ki 8751 Mar 2007
Potent, selective VEGFR-2 inhibitor
2495 Melperone hydrochloride Mar 2007
5-HT2A/D2 receptor antagonist; neuroleptic
2465 SDZ WAG 994 Mar 2007
Potent, selective A1 agonist
2574 PSB 06126 Mar 2007
NTPDase 3 inhibitor
2573 PSB 069 Mar 2007
Non-selective NTPDase inhibitor
2559 TPCA-1 Mar 2007
Potent, selective inhibitor of IKK-2
2611 IMD 0354 Mar 2007
Inhibitor of IKK-2
2550 SUN-B 8155 Mar 2007
Non-peptide calcitonin (CT) receptor agonist
2586 CFM 1571 hydrochloride Mar 2007
Soluble guanylyl cyclase (sGC) inhibitor
2657 JX 401 Mar 2007
Potent, reversible p38a inhibitor
2512 CGS 35066 Feb 2007
Endothelin-converting enzyme (ECE) inhibitor
0130 (+)-Bicuculline Feb 2007
Potent GABAA antagonist
2451 LY 344864 hydrochloride Feb 2007
Potent, selective 5-HT1F agonist
2473 GW 4064 Feb 2007
Selective farnesoid X receptor (FXR) agonist
2579 Zamifenacin fumarate Feb 2007
Selective M₃antagonist
2621 ARP 100 Feb 2007
Selective inhibitor of MMP-2
2655 Naproxen sodium Feb 2007
Cyclooxygenase inhibitor
2654 Compound W Feb 2007
g-secretase inhibitor
2460 Lazabemide hydrochloride Jan 2007
Selective MAO-B inhibitor
2529 UFP 803 Jan 2007
Urotensin II (UT) receptor antagonist
2526 UFP 112 Jan 2007
Potent NOP (ORL₁) agonist peptide
2629 Cilnidipine Jan 2007
Dual L/N-type Ca2+ channel antagonist
2554 CD 1530 Jan 2007
Potent and selective RARg agonist
2564 AM 114 Jan 2007
20S proteasome inhibitor
2585 Compstatin Jan 2007
C3-binding protein, inhibits complement activation
2637 Gliotoxin Jan 2007
Immunosuppressant; inhibits NFkB and cytokine production
2288 O-1918 Jan 2007
Silent antagonist for putative abnormal-CBD receptor
2414 H 1152 dihydrochloride Jan 2007
Selective rho-kinase (ROCK) inhibitor
2623 Oxaliplatin Jan 2007
DNA cross-linking antitumour agent
2626 Carboplatin Jan 2007
DNA cross-linking antitumour agent
1857 Burimamide oxalate Jan 2007
Mixed H₂/H₃antagonist
2625 Zonisamide Jan 2007
Blocks voltage-sensitive Na+ and T-type Ca2+ channels; anticonvulsant
1380 PMPA (NAALADase inhibitor) Jan 2007
Highly potent, selective NAALADase (GCP II) inhibitor
2563 Fexaramine Jan 2007
Potent, selective farnesoid X receptor (FXR) agonist
2561 Calmidazolium chloride Jan 2007
Calmodulin antagonist
2610 17-DMAG hydrochloride Jan 2007
Water-soluble Hsp90 inhibitor
2562 PB 28 dihydrochloride Jan 2007
High affinity s₂ agonist
2580 Tenidap Jan 2007
NSAID, cyclooxygenase (COX-1) inhibitor. Also opener of KIR2.3
2600 Clofarabine Dec 2006
Deoxycytidine kinase (dCK) substrate
2581 PAC 1 Dec 2006
Activator of procaspase-3; proapoptotic
2583 Omeprazole Dec 2006
H+,K+-ATPase inhibitor
2582 Lansoprazole Dec 2006
H+,K+-ATPase inhibitor
2287 K-252c Dec 2006
Protein kinase C inhibitor
2524 A 205804 Dec 2006
Selective inhibitor of E-selectin and ICAM-1 expression
2596 Mexiletine hydrochloride Dec 2006
Na+ channel blocker, antiarrhythmic agent
2533 DPO-1 Dec 2006
Blocker of Kv1.5 channel and IKur current
2484 (±)-AC 7954 hydrochloride Dec 2006
Non-peptide UT receptor agonist
2584 a-MSH Nov 2006
Endogenous melanocortin receptor agonist
2558 10-DEBC hydrochloride Nov 2006
Selective Akt/PKB inhibitor
2274 PPPA Nov 2006
Competitive NR2A antagonist
2569 CGP 42112 Nov 2006
Selective, high affinity AT2 ligand
2565 ZK 756326 Nov 2006
Selective, non-peptide CCR8 agonist
2450 NF 157 Nov 2006
Selective P2Y11/P2X1 antagonist
2578 Benazepril hydrochloride Nov 2006
Angiotensin-converting enzyme (ACE) inhibitor
2577 Cetirizine dihydrochloride Nov 2006
Selective H1 antagonist
2567 PLP (139-151) Nov 2006
Encephalitogenic myelin proteolipid fragment
2568 MOG (35-55) Nov 2006
Encephalitogenic myelin oligodendrocyte glycoprotein fragment
2576 Hemokinin 1 (human) Nov 2006
Endogenous, selective NK1 agonist
2039 CI 898 trihydrochloride Nov 2006
Dihydrofolate reductase inhibitor
2570 Kisspeptin 10 Nov 2006
Endogenous ligand for KISS1 receptor (hOT7T175/AXOR12/GPR54)
2566 Melanotan II Nov 2006
High affinity melanocortin receptor agonist
2571 Amlodipine besylate Nov 2006
Ca2+ channel blocker (L-type)
2545 Lofepramine Nov 2006
5-HT and noradrenaline re-uptake inhibitor (SNRI)
2531 Ganaxolone Nov 2006
Potent, positive allosteric modulator of GABAA receptors
2476 SR 11302 Nov 2006
Inhibitor of AP-1 transcription factor; antitumour agent
2435 CCT 018159 Nov 2006
Hsp90 inhibitor
2403 MRS 3777 hemioxalate Nov 2006
High affinity, selective A3 antagonist
2517 RS 504393 Nov 2006
Highly selective CCR2 chemokine receptor antagonist
2314 LOE 908 hydrochloride Nov 2006
Broad spectrum cation channel blocker; neuroprotective
2521 NSC 3852 Nov 2006
Histone deacetylase inhibitor
2530 PPDA Nov 2006
Subtype-selective NR2C/NR2D antagonist
2506 SSR 69071 Nov 2006
Potent, orally active human leukocyte elastase inhibitor
2549 ZIP Oct 2006
Cell-permeable inhibitor of atypical PKC isozyme PKMz
2383 Bryostatin 1 Oct 2006
Protein kinase C activator
2536 Domperidone Oct 2006
Peripheral D2-like antagonist
2547 6-Hydroxydopamine hydrochloride Oct 2006
Selective catecholaminergic neurotoxin
2453 LY 379268 Oct 2006
Highly selective group II mGlu agonist
2548 NF 110 Oct 2006
Potent P2X 3 antagonist
2261 L-692,585 Oct 2006
Potent, non-peptide GHS receptor agonist
2477 Proxyfan maleate Oct 2006
High affinity H3 ligand
2418 LY 303511 Oct 2006
Negative control of LY 294002 (Cat. No. 1130)
2534 LP 44 Oct 2006
High affinity 5-HT7 agonist
2434 L-759,656 Sep 2006
Highly selective CB2 agonist
2410 L-371,257 Sep 2006
Potent oxytocin receptor antagonist
2481 JTC 801 Sep 2006
Selective ORL1 antagonist
2504 Irsogladine maleate Sep 2006
PDE4 inhibitor; antiulcer agent
2544 Nafarelin Sep 2006
Gonadotropin-releasing hormone (GnRH) agonist
2148 (±)-McN 5652 Sep 2006
"Potent, orally active 5-HT uptake inhibitor. Also inhibits noradrenaline and dopamine uptake in vit
2510 Talniflumate Sep 2006
Chloride channel blocker (hCLCA1/mCLCA3 and Cl-/HCO3- exchange)
2382 EMD 386088 hydrochloride Sep 2006
Potent 5-ht6 agonist
2546 PKI 14-22 amide, myristoylated Sep 2006
Cell-permeable protein kinase A inhibitor
2086 GTP 14564 Sep 2006
Class III receptor tyrosine kinase (RTK) inhibitor
2501 Bay 36-7620 Sep 2006
Non-competitive mGlu1 antagonist with inverse agonist activity
1550 SC 560 Sep 2006
Cyclooxygenase (COX-1) inhibitor
2500 Bay 59-3074 Sep 2006
CB1/CB2 receptor partial agonist
2440 NNC 26-9100 Sep 2006
Selective sst4 agonist
2433 L-759,633 Sep 2006
High affinity, selective CB2 agonist
2174 Hispidulin Sep 2006
Partial positive allosteric modulator at the benzodiazepine receptor
2293 Zebularine Sep 2006
DNA methyltransferase and cytidine deaminase inhibitor
2505 Nonactin Sep 2006
Monovalent cation ionophore
2520 PD 166793 Sep 2006
Broad spectrum matrix metalloproteinase (MMP) inhibitor
1842 RHC 80267 Aug 2006
Diacylglycerol lipase inhibitor. Weak inhibitor of PLC and PLA2
1847 Eticlopride hydrochloride Aug 2006
Selective D2/D3 antagonist
2255 CGS 9343B Aug 2006
Calmodulin antagonist
1979 L-803,087 trifluoroacetate Aug 2006
Potent and selective sst4 agonist
2511 APC 366 Aug 2006
Tryptase inhibitor
2490 (±)-Clopidogrel hydrochloride Aug 2006
Selective P2Y12 antagonist
2272 Ro 08-2750 Aug 2006
Inhibitor of NGF-induced apoptosis
2538 L-BMAA hydrochloride Aug 2006
Neurotoxic amino acid
2513 Acyclovir Aug 2006
Antiherpetic agent
2443 RITA Aug 2006
p53-MDM2 interaction inhibitor; antitumour
2494 VUF 8430 dihydrobromide Aug 2006
Potent, high affinity H4 agonist
2493 VUF 5681 dihydrobromide Aug 2006
Potent H3 receptor silent antagonist
2436 AC 55649 Aug 2006
Selective RARb2 agonist
2158 MRS 2279 Aug 2006
Selective, high affinity P2Y1 antagonist
1994 ZK 93423 hydrochloride Aug 2006
Potent benzodiazepine agonist
2498 PNU 120596 Jul 2006
Positive allosteric modulator of a7 nAChR; active in vivo
1858 Impentamine dihydrobromide Jul 2006
Selective H3 antagonist
1849 EMD 66684 Jul 2006
Potent, selective non-peptide AT1 antagonist
2503 (-)-Bicuculline methiodide Jul 2006
Water-soluble GABAA antagonist
2492 MNITMT Jul 2006
Immunosuppressant
2496 DR 2313 Jul 2006
Potent PARP inhibitor
2491 Xaliproden hydrochloride Jul 2006
Orally active, high affinity 5-HT1A agonist
2475 ZM 323881 hydrochloride Jul 2006
Potent, selective inhibitor of VEGFR-2
2399 Indorenate hydrochloride Jul 2006
5-HT1A, 5-HT1B and 5-HT2C agonist
2425 Amyloid b-peptide (1-42) (rat) Jul 2006
Predominant amyloid b-protein fragment
2417 BIBU 1361 dihydrochloride Jul 2006
Selective inhibitor of EGFR-kinase
2499 ZM 306416 hydrochloride Jul 2006
Inhibitor of VEGF receptor tyrosine kinase
2483 Costunolide Jul 2006
Inhibitor of human telomerase activity
2471 ER 27319 maleate Jul 2006
Selective Syk kinase inhibitor
2463 SCH 442416 Jul 2006
Very selective, high affinity A2A antagonist
2424 Amyloid b-peptide (1-40) (rat) Jun 2006
Amyloid b-protein fragment
2467 CGS 20625 Jun 2006
Selective central benzodiazepine receptor partial agonist
2159 MRS 2500 tetraammonium salt Jun 2006
Extremely potent, selective P2Y1 receptor antagonist
2349 Dihydro-b-erythroidine hydrobromide Jun 2006
Antagonist for neuronal a4-containing nicotinic receptors
2276 FPL 55712 Jun 2006
Leukotriene receptor antagonist
2478 2-Pyridylethylamine dihydrochloride Jun 2006
H1 receptor agonist
2400 FK 888 Jun 2006
High affinity NK1 receptor antagonist
2457 Arcyriaflavin A Jun 2006
Potent cdk4/cyclin D1 and CaM Kinase II inhibitor. Antiviral agent (anti-HCMV)
2408 Ro 90-7501 Jun 2006
Inhibitor of Ab42 fibril formation
2459 Tropisetron hydrochloride Jun 2006
Potent 5-HT3 receptor antagonist; orally active
2479 JTE 907 Jun 2006
Selective CB2 receptor antagonist/inverse agonist
2268 NNC 55-0396 dihydrochloride Jun 2006
Highly selective T-type Ca2+ channel inhibitor
2458 ZM 447439 Jun 2006
Inhibits Aurora kinase B
2198 Mibefradil dihydrochloride Jun 2006
T-type Ca2+ channel blocker
1996 ZK 93426 hydrochloride Jun 2006
Potent, competitive benzodiazepine antagonist
2309 SR 142948 Jun 2006
Highly potent NT receptor antagonist
2157 MRS 2365 Jun 2006
Highly potent and selective P2Y1 agonist
2416 BIBX 1382 dihydrochloride May 2006
Highly selective EGFR-kinase inhibitor
2432 Anagrelide hydrochloride May 2006
Potent PDE3 inhibitor
2474 GW 3965 hydrochloride May 2006
Orally active liver X receptor (LXR) agonist
2452 LY 2183240 May 2006
Novel, potent anandamide uptake inhibitor. Inhibits FAAH
2415 HA 1100 hydrochloride May 2006
Cell-permeable, selective Rho-kinase inhibitor
2469 IBC 293 May 2006
Selective agonist for the GPR109b (HM74) receptor. Antilipolytic
2347 Salubrinal May 2006
Selective inhibitor of eIF2a dephosphorylation
2470 Nimesulide May 2006
Cyclooxygenase-2 (COX-2) inhibitor
2427 Apelin-36 (rat, mouse) May 2006
Endogenous APJ receptor ligand
2426 Apelin-36 (human) May 2006
Endogenous APJ receptor ligand
2445 Obestatin (rat) May 2006
Endogenous anorexigenic peptide
2456 Co 101244 hydrochloride May 2006
Highly selective NR2B antagonist
2423 DAPTA May 2006
Chemokine receptor 5 (CCR5) antagonist
2466 UK 14,304 tartrate May 2006
Water-soluble form of Cat. No. 0425
2375 Anti-p53 May 2006
Antibody recognising p53
2327 WIN 55,212-3 mesylate May 2006
CB2 antagonist/CB1 partial inverse agonist. Enantiomer of Cat. No. 1038
2304 Devazepide Apr 2006
Selective, orally active CCK1 receptor antagonist
2394 SDZ NKT 343 Apr 2006
Highly selective, human NK1 antagonist
2464 TNP-ATP triethylammonium salt Apr 2006
Potent, selective P2X antagonist
2273 PMPA (NMDA antagonist) Apr 2006
Competitive NMDA antagonist
2420 [Pyr1]-Apelin-13 Apr 2006
Potent peptide agonist for APJ receptor
2373 T 0901317 Apr 2006
Potent liver X receptor (LXR) agonist
2345 ZK 200775 Apr 2006
Competitive AMPA antagonist
2013 Guggulsterone Apr 2006
Broad spectrum steroid receptor ligand. Antagonises FXR and displays hypolipidaemic activity
2397 Eplerenone Apr 2006
Selective mineralocorticoid receptor antagonist
2448 YM 298198 hydrochloride Apr 2006
Highly potent, selective non-competitive mGlu1 antagonist
2421 Scriptaid Apr 2006
Histone deacetylase inhibitor
2442 CGP 53353 Mar 2006
Selective inhibitor of PKCbII
2019 PSB 36 Mar 2006
Potent, A1-selective antagonist
2446 AS 101 Mar 2006
Immunomodulator; inhibits IL-10 synthesis and potentiates IL-1a, IL-2 and TNFa release
1990 (R,R)-THC Mar 2006
Potent subtype selective ligand; ERa agonist/ERb antagonist
2392 JTE 013 Mar 2006
S1P2 receptor antagonist
2438 TMPH hydrochloride Mar 2006
Neuronal nicotinic receptor antagonist
2422 AKTide-2T Mar 2006
Akt/PKB substrate (synthetic)
2390 MPMQ hydrochloride Mar 2006
Selective mGlu1 antagonist
2447 Desmethyl-YM 298198 Mar 2006
Derivative of mGlu1 antagonist YM 298198
2131 Anti-c-Fos blocking peptide Mar 2006
Blocking peptide for Cat. No. 2066
2388 Anti-CB2 blocking peptide Mar 2006
Blocking peptide for Cat. No. 2231
2364 Anti-NCAM Feb 2006
Antibody recognising NCAM
2363 Anti-FGF-3 Feb 2006
Antibody recognising FGF-3
2310 SR 49059 Feb 2006
Selective, orally active vasopressin V1a receptor antagonist
2441 JNJ 10191584 maleate Feb 2006
Selective H4 receptor antagonist; orally active
2005 Ro 04-5595 hydrochloride Feb 2006
Selective NR2B antagonist
2322 BTS 54-505 hydrochloride Feb 2006
Potent SNRI; active metabolite of sibutramine (Cat. No. 2290)
2372 ABT 702 dihydrochloride Feb 2006
Adenosine kinase inhibitor; orally active
2374 GW 405833 Feb 2006
Selective, high affinity CB2 receptor partial agonist
2429 Fexofenadine hydrochloride Feb 2006
H1 receptor antagonist; non-sedating antiallergic agent
2387 LY 320135 Feb 2006
Selective CB1 receptor antagonist/inverse agonist
2281 2'-MeCCPA Feb 2006
Very selective and potent A1 receptor agonist
2037 SDZ 205-557 hydrochloride Feb 2006
5-HT4/5-HT3 receptor antagonist
2396 Glimepiride Feb 2006
K+ channel opener (KATP)
2315 Immethridine dihydrobromide Feb 2006
Potent H3 agonist, highly selective over H4
2409 Conessine Feb 2006
Potent and selective H3 receptor antagonist
1549 CD 437 Feb 2006
RARg-selective agonist
2404 Ambroxol hydrochloride Feb 2006
Na+ channel blocker
2066 Anti-c-Fos Feb 2006
Antibody recognising c-Fos
2231 Anti-CB2 Feb 2006
Antibody recognising CB2 receptors
2366 Anti-p14ARF Feb 2006
Antibody recognising p14ARF
2381 Anti-phospho-MDM2 (Ser186) Feb 2006
Antibody recognising MDM2 phosphorylated at Ser186
2308 Tabimorelin hemifumarate Feb 2006
Potent, orally active GHS receptor agonist
2339 WEB 2086 Jan 2006
Potent PAF receptor antagonist
2344 CGH 2466 dihydrochloride Jan 2006
A1, A2B and A3 antagonist and inhibitor of p38 MAPK and PDE4